Toronto-based Canntab Therapeutics Ltd., a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, announced last week that it has entered into an affiliate agreement with OnPharm–United, a 600-plus network of independent pharmacy owners throughout the Province of Ontario.
OnPharm-United works to provide its members with the ability to maintain their independent status while benefiting from increased buying and negotiating power. The network also provides access to a suite of innovative programs, services and resources.
All member pharmacies will have access to educational information on medical cannabis, Canntab’s exclusive hard tablet medical products including cannabidiol (CBD) and tetrahydrocannabinol (THC) and all necessary tools to permit the pharmacists to refer patients to the Canntab.ca website to fulfill their prescriptions for medical cannabis.
“This important relationship, with a large network of highly respected pharmacists, is a testament and recognition of the importance of the health benefits of medical cannabis as well as Canntab’s key role in delivering true pharmaceutical grade THC and CBD to those medical patients in a trusted and precise dosage format,” said Canntab CEO Larry Latowsky. “As an example, many pharmacies are either in proximity or often affiliated with pain clinics and therefore providing both the pharmacist and patient with ease of access to the necessary information required to access medical cannabis and the Canntab solid oral dose offerings.”
Fady Fares, co-CEO of OnPharm-United, said the agreement with Canntab is consistent with his company’s objective to enable independent pharmacies to thrive in a highly competitive and continuously changing market. “This agreement will help to keep our network of pharmacies at the leading edge of medical cannabis from an educational and professional development perspective,” explained Fares. “Our partnership with Canntab is a tremendous fit for our members and their patients.”
Latowsky went on to add “the pharmacy affiliate program will significantly extend and leverage our reach to a greater population and with the potential of adding a significant number of patients for Canntab’s medical cannabis offerings. We believe that this is only one of many other affiliate agreements which Canntab hopes to enter into with other pharmacy networks.”
Canntab is a Canadian phytopharmaceutical company focused on the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations. Canntab holds a Cannabis Standard Processing & Sales for Medical Purposes License and a Cannabis Research License.
